Results 181 to 190 of about 70,541 (322)

Dabigatran and other oral antithrombotic agents for the prevention of stroke in patients with atrial fibrillation

open access: yesResearch Reports in Clinical Cardiology, 2011
Fernando D Testai, Venkatesh AiyagariSection of Neurological Critical Care and Stroke, Department of Neurology and Rehabilitation, Center for Stroke Research, University of Illinois College of Medicine, Chicago, IL, USAAbstract: Atrial fibrillation (AF ...
Testai F, Aiyagari V
doaj  

Levodopa–Entacapone–Carbidopa Intrajejunal Infusion in Advanced Parkinson's Disease – Interim Analysis of the ELEGANCE Study

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Levodopa–entacapone–carbidopa intestinal gel (LECIG) was introduced in 2018 as a device‐aided therapy for advanced Parkinson's disease (PD). Objectives The ELEGANCE study (NCT05043103) is gathering real‐world data on long‐term efficacy, safety and patient‐reported outcomes with LECIG from 13 European countries.
Daniel Weiss   +10 more
wiley   +1 more source

Eldecalcitol improves chair-rising time in postmenopausal osteoporotic women treated with bisphosphonates

open access: yesTherapeutics and Clinical Risk Management, 2014
Jun Iwamoto,1 Yoshihiro Sato21Institute for Integrated Sports Medicine, Keio University School of Medicine, Tokyo, Japan; 2Department of Neurology, Mitate Hospital, Fukuoka, JapanAbstract: An open-label randomized controlled trial was conducted to ...
Iwamoto J, Sato Y
doaj  

Opicapone in Parkinson's Disease on Levodopa‐Carbidopa Intestinal Gel Treatment: A Pilot, Randomized Study

open access: yesMovement Disorders Clinical Practice, EarlyView.
ABSTRACT Background Levodopa‐carbidopa intestinal gel infusion (LCIG) is an effective therapy for advanced Parkinson's disease (PD). Opicapone (OPC) is an enzyme inhibitor that enhances the bioavailability of levodopa in the brain. Objectives This study evaluates the effect of Opicapone addition in PD‐LCIG patients, assessing its impact on motor ...
Fabiana Colucci   +9 more
wiley   +1 more source

Exploring the Link: Vitamin D Levels and Its Clinical Implications in Guillain-Barré Syndrome Patients. [PDF]

open access: yesNeurohospitalist
Lopez-Pizano A   +5 more
europepmc   +1 more source

Environmental risk factors for multiple sclerosis: a comprehensive systematic review and meta-analysis. [PDF]

open access: yesJ Neurol
Vitturi BK   +8 more
europepmc   +1 more source

A Systematic Review of Attributes Influencing Preferences for Treatments and Interventions in People With Amyotrophic Lateral Sclerosis (ALS)

open access: yesMuscle &Nerve, EarlyView.
ABSTRACT Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that has no cure, and treatments predominantly focus on improving quality of life. Patient‐centred care is central to bringing about meaningful improvements to quality of life.
A. Clift   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy